<aside> 🔎 ProvaLabs Aims to Provide Innovative Sensor Solutions to Accelerate Drug Discovery
Microphysiological models’ reliability must be assured before they can provide physiologically accurate preclinical evaluation data. The quality and completeness of such cell culture models are crucial factors. However, conventional quality tests are vague and often destructive.
ProvaLabs’ ScalloP™ provides a highly reliable non-destructive evaluation of the biological models, with detailed spatial trans-epithelial electrical resistance profiles. Researchers can now quantitatively understand the barrier function and physiology of the disease models.
Experts expect to see the cost saving at 26%, when proper model systems are implemented, particularly in the preclinical phases of drug development. We pave the way for time- and cost-effective drug discovery, while the current cost estimation hits 12+yrs & $2.3B in USD.